A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Clinical trial NCT05872620 · COMPLETED
Trial details
- NCT number
- NCT05872620
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2025-08-08
- Enrollment
- 1613
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.